After delivering 150% earnings growth last quarter, Wall Street estimates call for diabetes management leader Insulet (PODD) to post a 261% EPS spike for the full year. That has PODD stock setting up ...
Tag: Insulet
Dexcom Stock Plummets On Rumor It Could Acquire Insulet In A ‘Transformative’ Deal
Dexcom stock tumbled Tuesday on rumors that it’s in talks to acquire insulin pump-maker Insulet (PODD). X The potential deal, first reported by Bloomberg, would create a behemoth in diabetes man...